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ABSTRACT
Head and neck cancer is the 6th most common cancer 
worldwide, accounting for 5 to 6% of all cancer cases. Surgical 
resection and/or radiotherapy have long been regarded as the 
standard treatment, while chemotherapy can be added as an 
adjunct. However, conventional chemotherapy has certain 
drawbacks like nonspecific distribution, short circulation time, 
and tumor resistance. Recently, targeted therapeutics with 
nanoparticles have emerged as promising alternatives to 
overcome these drawbacks of conventional approaches and 
among the diverse classes of nanomaterials, carbon nanotubes 
(CNTs), due to their unique physicochemical properties, have 
become a popular tool in cancer diagnosis and therapy. 
Carbon nanotubes are tubular materials with nanometer-sized 
diameters and axial symmetry, with unique properties, such as 
ease of cellular uptake, high drug loading, and thermal ablation, 
which render them useful for cancer therapy. The important 
biomedical applications of CNTs include their contribution in the 
field of drug delivery, thermal therapy, photodynamic therapy, 
gene delivery, biological detection, and imaging. More recently, 
they have also been used as vehicles for antigen delivery, a 
novel immunization strategy against infectious diseases and 
cancer. These multifunctional and multiplex nanoparticles are 
now being actively investigated and are on the horizon as the 
next generation of nanoparticles, facilitating personalized and 
tailored cancer treatment. However, concerns over certain 
issues, such as biocompatibility and toxicity have been raised 
and warrant extensive research in this field.
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INTRODUCTION
Cancer is one of the leading causes of death worldwide. 
According to the World Cancer Report 2012 issued by 
the World Health Organization, there were an estimated 
14.1 million new cases of cancer worldwide in 2012 and 
8.2 million deaths from the disease.1 Early radical resection 
of the tumor is the most desirable treatment, but only a few 
cases are diagnosed at an early stage. However, for most 
patients local invasion and distant metastasis are present 
at the time of diagnosis. For those unoperable patients and 
those who received palliative operation, chemotherapy and 
radiotherapy are the mainstay. Since chemotherapeutic 
drugs affect all rapidly dividing cells, including the healthy 
cells, they can cause several undesirable effects in the 
patient’s body. Therefore, the challenge is to develop new 
methods for early detection of cancer and targeted delivery 
of drugs to the cancerous cells only. Recently, targeted 
therapeutics with nanoparticles have gained prominence 
in the biomedical field,2-4 and among these diverse classes 
of nanomaterials, carbon nanotubes (CNTs) have attracted 
particular attention due to their unique physicochemical 
properties. Since past 18 years, different CNT preparations 
have been reported to be used in drug delivery, cellular 
therapy, and more recently in molecular imaging and as 
sensors for cancer biomarker detection in serum.5-7
CARBON NANOTUBeS: STRUCTURe  
AND PROPeRTIeS
Carbon nanotubes, first discovered by Iijima in 1991,8 
can be imagined as the cylindrical roll-up of one or more 
graphene sheets containing only sp2 hybridized carbon 
atoms in a honeycomb arrangement.9 Both ends of the 
tubes are capped by a hemispherical arrangement of 
carbon networks called fullerenes, formed by warping of 
the graphene sheet. Structurally, CNTs are of two types: 
single-walled carbon nanotubes (SWCNTs), which con-
sist of one layer of cylinder graphene, and multi-walled 
(MWCNTs) carbon nanotubes, which contain several 
concentric graphene sheets. The length of the nanotubes 
ranges from several hundred nanometers to several 
millimeters, but their diameters depend on their class, 
diameter of MWCNT being greater than that of SWCNT. 
Carbon nanotubes possess remarkable properties, such as 
high aspect ratio, ultra-light weight, tremendous strength, 
high thermal conductivity, and significant electronic 
Carbon Nanotubes: A Novel Approach for Cancer 
Diagnosis and Therapy
1ML Asha, 2Laboni Ghorai, 3Basetty N Rajarathnam, 4HM Mahesh Kumar, 5J Lekshmy, 6Srilakshmi Jasti
JOFR
Review ARticle
10.5005/jp-journals-10026-1187
1Professor and Head, 2,6Postgraduate Student, 3-5Senior 
Lecturer
1-6Department of Oral Medicine and Radiology, Syamala  
Reddy Dental College, Hospital and Research Centre, Bengaluru 
Karnataka, India
Corresponding Author: Laboni Ghorai, Postgraduate 
Student, Department of Oral Medicine and Radiology, Syamala 
Reddy Dental College, Hospital and Research Centre, #111/1 
SGR College Main Road, Munnekolala Marathahalli (Post) 
Bengaluru, Karnataka, India, Phone: +919035709695, e-mail: 
dr.labonidey@gmail.com
Carbon Nanotubes in Cancer Diagnosis and Therapy
Journal of Orofacial Research, July-September 2015;5(3):84-89 85
JOFR
properties ranging from metallic to semiconducting. 
However, in the field of cancer diagnostic and therapeu-
tic, three main attributes of CNTs have been exploited: 
•	 	Being	small	in	size,	they	can	pass	through	the	leaky	
vasculature within the tumor or can transport deoxy-
ribonucleic acid (DNA).
•	 	High	surface	area	 to	volume	ratio	provides	a	good	
platform for their ability to efficiently transport 
different chemicals. 
•	 	Their	ability	to	contain	chemicals.
Although in recent years a variety of different 
nanocarriers have been evaluated, CNTs have potential 
advantages over the others. The advantages include:
•	 	Ability	to	carry	a	high	cargo	loading,	intrinsic	stability,	
and structural flexibility, which will lead to increased 
circulation time, resulting in better bioavailability of 
the drug molecules carried. 
•	 Ability	to	enter	the	mammalian	cells.	
•	 	Requirement	of	 lesser	quantity	of	 the	drug	 for	 the	
desired effect.
•	 	No	requirement	of	solvent	for	drug	delivery,	thereby	
preventing undesired health effects from the solvent. 
•	 	No	risk	of	the	protective	nanocarrier	degrading.
•	 	A	range	of	drugs	can	be	attached	for	therapeutic	and	
diagnostic purposes.10
CARBON NANOTUBeS: APPLICATIONS
Due to their amazing properties, CNTs have diverse 
applications in the field of cancer diagnosis and therapy. 
The important applications include:
•	 Applications	in	cancer	diagnosis
– Molecular imaging with SWCNTs
– Cancer biomarker detection
•	 Applications	in	cancer	therapy
– Drug delivery
– Lymphatic targeted chemotherapy
– Thermal therapy
– Photodynamic therapy
– Gene therapy.
Applications in Cancer Diagnosis
Molecular Imaging with SWCNTs
Since radical resection of the tumor at its early stage is 
the treatment of choice, early screening and detection are 
of immense importance. Most cancers are asymptomatic 
during their early stage. Since the conventional clinical 
cancer imaging techniques, such as film radiography, 
computed tomography (CT), magnetic resonance imaging 
(MRI), and diagnostic ultrasonography (USG), require a 
macroscopic anatomic change for information to be recorded 
by an image receptor, they can easily avoid being detected by 
these imaging techniques. On the other hand, radionuclide 
imaging, such as positron emission tomography, though 
identifies early-stage alterations in molecular biology, 
is not specific for malignant diseases but for increased 
metabolism.11-13 Hence, it is imperative to develop new 
aids for early cancer diagnosis. Hong et al first reviewed 
molecular imaging with SWCNTs. Carbon nanotubes can 
act as a contrast medium in different imaging modalities, 
such as magnetic resonance, near-infrared fluorescence, 
Raman spectroscopy, photoacoustic tomography, 
and radionuclide-based imaging, where gadolinium-
functionalized ultra-short SWCNT (gadonanotube) 
improved resolution, sensitivity, and tissue penetration as 
compared with the traditional contrast agents.14
Cancer Biomarker Detection
Cancer cells often overexpress characteristic protein 
biomarkers, which provide an opportunity for early 
diagnosis of the disease. Carbon nanotube exhibiting 
unique electronic, mechanical, and thermal properties 
has been proposed as a promising tool for detecting the 
expression of indicative biological molecules at early 
stage of cancer with high sensitivity, selectivity, rapidity, 
and low detection limit. Yu et al in 2006 reported a 
combination of electrochemical immunosensors using 
SWCNT forest platform with multilabel secondary 
antibody–nanotube biconjugates for highly sensitive 
detection of a cancer biomarker in serum and tissue 
lysates. Although further research is required in this field, 
it is believed that CNT-based detecting measurement 
may serve as an alternative method for cancer biomarker 
diagnosis in clinical analysis in the future.15
Applications in Cancer Therapy
Drug Delivery by CNTs
Chemotherapy is generally used alongside surgery and/
or radiotherapy in advanced cancer cases. The most 
common chemotherapeutic agents used are platinum-
based drugs (cisplatin or carboplatin) and combinations 
with taxanes (e.g., docetaxel) or 5-fluorouracil. Clinical 
studies revealed that approximately 30% of patients 
with advanced head and neck squamous cell carcinoma 
responded to a single agent, such as cisplatin or 
5-fluorouracil, but no improvement in overall survival 
was observed.16 A combination of chemotherapeutic 
agents did improve the drug response but had no effect 
on overall survival.17 The conventional delivery methods 
of chemotherapeutic agents have several limitations:
•	 	First,	 some	 drugs	 have	 poor	 solubility	 and	 low	
bioavailability and contain toxic solvents in their 
formulation. 
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•	 	Second,	 they	have	a	 short	 circulation	 time	because	
of their physiological instability, degradation, and 
clearance. 
•	 	Third,	 the	 nonspecific	 distribution	 of	 the	 drugs	
limits the concentration achieved in the tumor, and 
causes harmful side effects because of their unwanted 
accumulation in healthy tissues.16
Therefore, advanced drug delivery systems (DDS), 
based on nanotechnology and a tumor-targeted strategy, 
hold considerable potential to enhance chemotherapeutic 
efficacy. Researchers have found that functionalized 
CNTs with the help of specific peptides or ligands on 
their surface to recognize cancer-specific receptors 
on the cell surface, can carry therapeutic drugs more 
safely and effectively into the cells that were previously 
unreachable, which makes them ideal candidates for 
drug delivery.5
These delivery systems generally consist of three 
parts:
•	 Functionalization	of	CNTs
•	 Anticancer	drug	loading
•	 Drug	targeting
Functionalization of CNTs: Functionalization is a process of 
attachment of appropriate molecules to the CNT surface 
to evade the host defenses and to make them more 
biocompatible and less toxic. Carbon nanotube tips have 
a higher affinity for binding functional groups than the 
sidewalls.18 Functionalization can be done noncovalently 
or covalently. Noncovalent functionalization involves 
van der Waals interactions, π–π interactions, and 
hydrophobic interactions of biocompatible groups with 
the surface of CNT. This method preserves the aromatic 
structure and electronic characteristics of CNTs, but 
the bonding being weak it is not suitable for targeted 
drug delivery applications. Covalent functionalization 
involves oxidation of CNTs with strong acid, which 
attaches COOH group to the sidewall of CNTs rendering 
them water soluble and biocompatible. Biocompatibility 
may be enhanced by further coating with polyethylene 
glycol (PEG), which is a hydrophilic substance. Thus, this 
method is suitable for use as a DDS.19
Anti-cancer drug loading: The location of the drug to 
be delivered by the CNT can be internal or external. 
Internalization relies on van der Waals force for 
insertion into the CNT and is the best method for the 
drugs that are sensitive to external environment and 
easily broken. 
In this process, CNT caps are first opened by electric 
current or with acid. The most common mechanism for 
filling CNTs is by capillarity. Drugs can attach to the 
CNT via the functional group either by covalent bonding 
where a linker with which both the drug and CNT react 
to form covalent bond is used or by noncovalent bonding, 
which involves physical conjugation of the anticancer 
drug to CNT via hydrophobic interaction, π–π stacking, 
or electrostatic adsorption. Then, the CNTs are washed 
with a solution, i.e., less soluble for the impregnating 
fluid and can dissolve only the deposits left outside CNT. 
Finally, CNTs are capped by passing a current that fuses 
the ends closed.10
Drug targeting: Accumulation at a targeted location is 
important in DDS. Targeted nanoscale drug deliveries 
are of two types: passive targeting and active targeting. 
In passive targeting, PEGylated conjugates are 
delivered to the tumor tissue in increased amount due 
to the effect of enhanced permeability and retention 
(EPR). Due to angiogenesis, the new blood vessels that 
are formed are leaky, promoting increased permeability 
of nanoparticles. Poor lymphatic drainage in tumor also 
causes retention of nanoparticles. This combined effect 
is called EPR.
Active targeting uses antibody- or ligand-targeted 
binding as a means of selective delivery to cancer cell 
or tumor.10
After targeted delivery, anticancer drug will be 
released in cancer cell by different techniques: 
•	 	Extracellular	tumor	tissue	and	intracellular	lysosomes	
and endosomes are acidic and may help in release of 
anticancer drug at low pH.
•	 	Heat	 in	 acidic	 environment	may	help	 in	 release	of	
drug.
•	 	Cleavage	of	disulfide	bond	by	thiol-reducing	enzyme	
may help in release of drug.20,21
Carbon Nanotubes in Lymphatic Targeting
Lymphatic metastasis is common in cancers and often 
contributes to tumor recurrence, even after extended 
lymph node dissection. carbon nanotubes can be used 
to effectively block the metastasis of cancers through 
the lymphatic system. A lymphatic targeted DDS has 
been developed using magnetic multiwalled carbon 
nanotubes (mMWCNTs), which successfully delivered 
anticancer drug to lymph nodes with high efficiency 
under the guidance of a magnetic field.22-24 In another 
approach, poly(acrylic acid)-grafted MWCNTs have been 
tried, which were seen only in the local lymphatic nodes 
sparing the major organs, after 3 hours of subcutaneous 
injection, suggesting that they may have the potential to 
be used as a vital staining dye and simplify lymph node 
identification during surgery even when they are very 
small.25,26 Thus, without the help of such nanostructures, 
anticancer drugs cannot preferentially distribute in the 
lymphatic system.
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Thermal Therapy Applications
There has been much interest in the use of CNTs in 
conjunction with radiofrequency and laser therapy 
in cancer treatment. Thermal ablation above 55°C has 
shown coagulative necrosis and protein denaturation 
of the malignant cells and also the permeability of the 
tumor vasculature is increased due to the local rise in 
temperature. The transmission of laser beams could be 
divided into two different types: short laser nanosecond 
exposure and long laser exposure. Nanosecond exposure 
is usually used for the ablation of metastatic or individual 
tumor cells. Although temperatures using this method 
can reach a maximum of 300°C, its nanosecond exposure 
ensures minimal damage to surrounding tissues. The 
second method requires a few minutes of laser exposure 
and is generally used for ablation of primary cancer 
cells that are relatively large in size. The latter usually 
disables cell function by thermal protein denaturation 
and, unlike short laser exposure, may affect healthy cells 
as well as cancer cells. The temperature range for this 
type of laser is typically 45 to 65°C. Also, laser, being a 
single point source of thermal energy, results in uneven 
tumor heating, or production of tumor seeding along the 
needle track that can result in tumor recurrence. Carbon 
nanotube-mediated thermal ablation has potential 
advantages over the conventional ones. The advantages 
include:
•	 	Targeting	of	malignant	 tumor	 site	 specifically	 and	
selectively ablating the tumor cells
•	 	Prevention	of	uneven	tumor	heating
•	 Prevention	of	tumor	seeding
•	 	Production	of	temperature	gradients	that	extend	more	
deeply into the tissue
•	 	Ability	 to	carry	magnetic	nanoparticles,	which	can	
be localized in deep tissue, fixed at a specific position 
by an external magnetic field and then alteration of 
the alternating current field can be used to change 
the temperature of the magnetic nanoparticles. 
Here, CNT acts as a shell, protecting the biological 
environment against oxidation and toxicity of the 
magnetic nanoparticles.27-32
Carbon Nanotube-mediated Photodynamic Therapy
The use of CNTs as a new photosensitizer for photo- 
dynamic therapy (PDT) is another area of research cur-
rently under investigation. Photodynamic therapy is a 
confined therapy capable of efficiently destroying tumors 
while at the same time sensitizing the immune system 
to seek out and destroy metastases. Hence, it could be a 
better alternative for cancer therapy in comparison to the 
conventional treatments like surgery, radiation therapy, 
and chemotherapy, which tend to be immunosuppres-
sive.33 Singlet oxygen generated during PDT can react 
rapidly with cellular molecules and mediate cellular 
toxicity to cause cell damage, ultimately leading to cell 
death. However, the lifetime and diffusion distance of 
singlet oxygen are very limited. To overcome this draw-
back, CNT-based PDT with a novel molecular complex 
of a photosensitizer consisting of an single-stranded 
DNA aptamer and SWCNTs has been developed by Zhu 
et al,34 which can control and regulate singlet oxygen 
generation. However, presently the knowledge of CNT-
based PDT is limited and further research is needed in 
this area.
Delivery of Therapeutic Gene by CNTs
Gene therapy involving transport of the correct gene 
by viral or nonviral vectors to the affected area is the 
most promising method in cancer treatment and is 
expected to be an alternative method to traditional 
chemotherapy. Although viral gene delivery achieves a 
high level of gene expression, the currently used viral 
vectors are immunogenic and have limited packaging 
capacity. These limitations have made nonviral vectors 
an attractive alternative to viral vectors. However, the 
nonviral vectors have lower efficiency of gene expression 
due to poor pharmacokinetic profile. Carbon nanotubes 
seem to represent a very good nonviral vector for gene 
therapy because of low immunogenicity, good membrane 
penetration, higher level of gene expression compared 
with the naked DNA alone and ability to transfer DNA 
without degradation.35-40 Thus, it is believed that CNT-
based gene transfer vector systems will play a great role 
in the treatment of cancer in the future.
CARBON NANOTUBeS: TOXICITY
Although there are exciting prospects for the application 
of CNTs in medicine, concerns over adverse and 
unanticipated effects on human health have also been 
raised. 
•	 	Carbon	 nanotubes	may	 exert	 dose-dependent	
cytotoxicity, a high dose of nanoparticles having major 
impact on toxicity.41
•	 	Toxicity	may	be	relevant	to	the	route	of	administration,	
the subcutaneous route of administration being the 
least toxic.23
•	 	Carbon	nanotubes	seem	to	possess	fibrous	character-
istics having high length-to-diameter (aspect) ratio 
resulting in low solubility.42,43
•	 	Carbon	nanotubes	have	been	found	to	be	associated	
with defective phagocytosis, leading to chronic 
inflammation.44
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•	 	Low	clearance	rate	of	CNTs	could	lead	to	the	formation	
of granulomas.45
CONCLUSION
The introduction of nanotechnology in biological systems 
has led to the beginning of a new chapter in the field 
of research. The novel properties of carbon nanotubes 
allow them to be multifunctional therapeutic agents in 
cancer treatment. However, a detailed understanding 
of the pharmacological and toxicological properties of 
CNTs and a balanced evaluation of risk/benefit ratio 
are required before they can be implemented for routine 
clinical use.
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